← Leaderboards

Robert E Reiter

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗

$11,316,970

Attributed

$12,952,252

Total exposure

15

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY2007–23

$5M$3.8M$2.5M$1.3M$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$44,539,528 · 16

By mechanism

P50$41,099,607 · 14

R01$3,270,565 · 1

K08$169,356 · 1

Top collaborators

Anna M Wu8 shared

Most similar at University Of California Los Angeles

Same institution · by research overlap

Sanjiv S Gambhir$44,452,033
Judith S. Currier$525,401,794
Steven Shoptaw$45,062,464
Jerome A. Zack$38,514,975
Steven Grant Deeks$52,964,444

Others in their field

Top investigators on “Malignant Neoplasm Of Prostate”

David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Walter John Curran · Thomas Jefferson University$61,298,085
Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
James J. Dignam · University Of Chicago$48,310,409
Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962

Research focus

Malignant Neoplasm Of ProstateProgramsResearch PersonnelTranslational ResearchAreaInnovationProstateBaseFundingResearch Project GrantsAnticancer ResearchDiagnosisClinicImageMorbidity - Disease RateNeoplasm MetastasisCancer EtiologyBudgetsCessation Of LifeMonitorMolecularResistanceProstate Stem Cell AntigenLeadership

Grant awards (77)

UCLA SPORE in Prostate Cancer$1,599,812

P50 · FY2023 · CA · contact PI

Administrative Core$266,582

P50 · FY2023 · CA · contact PI

Career Enhancement Program$72,538

P50 · FY2023 · CA · contact PI

Developmental Research Program$72,538

P50 · FY2023 · CA · contact PI

UCLA SPORE in Prostate Cancer$1,643,637

P50 · FY2022 · CA · contact PI

Administrative Core$270,178

P50 · FY2022 · CA · contact PI

Developmental Research Program$61,532

P50 · FY2022 · CA · contact PI

Career Enhancement Program$61,531

P50 · FY2022 · CA · contact PI

UCLA SPORE in Prostate Cancer$1,443,180

P50 · FY2021 · CA · contact PI

Administrative Core$266,584

P50 · FY2021 · CA · contact PI

Career Enhancement Program$72,538

P50 · FY2021 · CA · contact PI

Developmental Research Program$72,538

P50 · FY2021 · CA · contact PI

UCLA SPORE in Prostate Cancer$1,449,094

P50 · FY2020 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$358,858

R01 · FY2020 · CA

Administrative Core$243,612

P50 · FY2020 · CA · contact PI

Career Enhancement Program$66,289

P50 · FY2020 · CA · contact PI

Developmental Research Program$66,289

P50 · FY2020 · CA · contact PI

UCLA SPORE in Prostate Cancer$1,708,652

P50 · FY2019 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$348,092

R01 · FY2019 · CA

Administrative Core$266,582

P50 · FY2019 · CA · contact PI

Career Enhancement Program$72,540

P50 · FY2019 · CA · contact PI

Developmental Research Program$72,540

P50 · FY2019 · CA · contact PI

UCLA SPORE in Prostate Cancer$1,162,609

P50 · FY2018 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$377,890

R01 · FY2018 · CA

Administrative Core$235,568

P50 · FY2018 · CA · contact PI

Developmental Research Program$214,161

P50 · FY2018 · CA · contact PI

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$182,064

P50 · FY2018 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,300,000

P50 · FY2017 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$444,176

R01 · FY2017 · CA

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$270,536

P50 · FY2017 · CA · contact PI

Developmental Research Program$264,974

P50 · FY2017 · CA · contact PI

Career Development Program$218,761

P50 · FY2017 · CA · contact PI

Administrative Core$191,030

P50 · FY2017 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,157,312

P50 · FY2016 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$444,176

R01 · FY2016 · CA

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$253,748

P50 · FY2016 · CA · contact PI

Developmental Research Program$248,532

P50 · FY2016 · CA · contact PI

Career Development Program$205,228

P50 · FY2016 · CA · contact PI

Administrative Core$179,243

P50 · FY2016 · CA · contact PI

UCLA SPORE in Prostate Cancer$100,000

P50 · FY2016 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,185,000

P50 · FY2015 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$447,370

R01 · FY2015 · CA

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$258,636

P50 · FY2015 · CA · contact PI

Developmental Research Program$253,082

P50 · FY2015 · CA · contact PI

Career Development Program$206,967

P50 · FY2015 · CA · contact PI

Administrative Core$179,296

P50 · FY2015 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,162,000

P50 · FY2014 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$402,633

R01 · FY2014 · CA

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$253,601

P50 · FY2014 · CA · contact PI

Developmental Research Program$248,387

P50 · FY2014 · CA · contact PI

Career Development Program$205,118

P50 · FY2014 · CA · contact PI

Administrative Core$179,159

P50 · FY2014 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,150,500

P50 · FY2013 · CA · contact PI

Multifunctional immunoPET tracers for pancreatic and prostate cancer$447,370

R01 · FY2013 · CA

Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer$256,992

P50 · FY2013 · CA · contact PI

Developmental Research Program$246,420

P50 · FY2013 · CA · contact PI

Career Development Program$203,409

P50 · FY2013 · CA · contact PI

Administrative Core$177,602

P50 · FY2013 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,185,000

P50 · FY2011 · CA · contact PI

Imaging Prostate Cancer with Engineered PSCA Antibodies$403,958

P50 · FY2011 · CA · contact PI

IPBS Supplement$10

P50 · FY2011 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,300,000

P50 · FY2010 · CA · contact PI

Imaging Prostate Cancer with Engineered PSCA Antibodies$425,218

P50 · FY2010 · CA · contact PI

IPBS Supplement$11

P50 · FY2010 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,348,217

P50 · FY2009 · CA · contact PI

Imaging Prostate Cancer with Engineered PSCA Antibodies$425,125

P50 · FY2009 · CA · contact PI

IPBS Supplement$48,776

P50 · FY2009 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,346,813

P50 · FY2008 · CA · contact PI

Imaging Prostate Cancer with Engineered PSCA Antibodies$425,395

P50 · FY2008 · CA · contact PI

IPBS Supplement$47,362

P50 · FY2008 · CA · contact PI

UCLA SPORE in Prostate Cancer$2,345,450

P50 · FY2007 · CA · contact PI

Imaging Prostate Cancer with Engineered PSCA Antibodies$397,476

P50 · FY2007 · CA · contact PI

Administrative Core$159,275

P50 · FY2007 · CA · contact PI

IPBS Supplement$42,800

P50 · FY2007 · CA · contact PI

Prostate Stem Cell Antigen (PSCA in prostate cancer$0

P50 · FY2002 · CA

MARKERS OF ANDROGEN INDEPENDENT PROSTATE CANCER$84,678

K08 · FY2001 · CA

MARKERS OF ANDROGEN INDEPENDENT PROSTATE CANCER$84,678

K08 · FY2000 · CA